Carson Wealth (CWM LLC)
DRUG

Carson Wealth (CWM LLC)’s Bright Minds Biosciences DRUG Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$803 Buy
11
+1
+10% +$80 ﹤0.01% 5427
2025
Q4 		$1K Buy
10
+4
+67% +$267 ﹤0.01% 5200
2025
Q3 		$0 Buy
+6
New +$233 ﹤0.01% 5326

Other funds holding DRUG

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Carson Wealth (CWM LLC)'s DRUG Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Bright Minds Biosciences (DRUG) stake by 10% in Q1 2026, buying an estimated $80 and bringing the position to 11 shares worth $803. The position accounts for ﹤0.01% of the portfolio, ranked #5427.

Carson Wealth (CWM LLC) first reported a position in DRUG in Q3 2025 and has held it in 3 quarters since. The position peaked at $1K in Q4 2025. 94 funds tracked by Wall St. Rank hold DRUG as of Q1 2026.

  • Carson Wealth (CWM LLC) held 11 shares of Bright Minds Biosciences worth $803 as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 1 Bright Minds Biosciences share in Q1 2026, an estimated $80.
  • Bright Minds Biosciences made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5427 holding.
  • Carson Wealth (CWM LLC) first reported a position in Bright Minds Biosciences in Q3 2025 and has held it in 3 quarters since.
  • Carson Wealth (CWM LLC)'s Bright Minds Biosciences position peaked at $1K in Q4 2025.
  • 94 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.